Citations (182)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (27)
Venkat S. Manubolu & Matthew J. Budoff. (2022) Achieving coronary plaque regression: a decades-long battle against coronary artery disease. Expert Review of Cardiovascular Therapy 20:4, pages 291-305.
Read now
Read now
Renate D. Laumann, Turid Iversen, Pernille R. Mogensen, Lotte Lauritzen, Christian Mølgaard & Thomas L. Frandsen. (2021) Effect of Fish Oil Supplementation on Hyperlipidemia during Childhood Acute Lymphoblastic Leukemia Treatment – A Pilot Study. Nutrition and Cancer 73:9, pages 1816-1820.
Read now
Read now
John R. Nelson, Matthew J. Budoff, Omar R. Wani, Viet Le, Dhiren K. Patel, Ashley Nelson & Richard L. Nemiroff. (2021) EPA’s pleiotropic mechanisms of action: a narrative review. Postgraduate Medicine 133:6, pages 651-664.
Read now
Read now
Rana Shafabakhsh, Željko Reiner, Jamal Hallajzadeh, Liaosadat Mirsafaei & Zatollah Asemi. (2021) Are anti-inflammatory agents and nutraceuticals - novel inhibitors of PCSK9?. Critical Reviews in Food Science and Nutrition 61:2, pages 325-336.
Read now
Read now
Yasuhiro Watanabe & Ichiro Tatsuno. (2021) Omega-3 polyunsaturated fatty acids focusing on eicosapentaenoic acid and docosahexaenoic acid in the prevention of cardiovascular diseases: a review of the state-of-the-art. Expert Review of Clinical Pharmacology 14:1, pages 79-93.
Read now
Read now
Sheila A Doggrell. (2019) Clinical trials of eicosapentaenoic acid (EPA) prescription products for the treatment of hypertriglyceridemia. Expert Opinion on Pharmacotherapy 20:10, pages 1221-1225.
Read now
Read now
Yasuhiro Watanabe & Ichiro Tatsuno. (2017) Omega-3 polyunsaturated fatty acids for cardiovascular diseases: present, past and future. Expert Review of Clinical Pharmacology 10:8, pages 865-873.
Read now
Read now
S. S. Iyengar, R. Puri, S. N. Narasingan, D. R. Nair, V. Mehta, J. C. Mohan, S. K. Wangnoo, J. J. Dalal, V. Jha, S. Puri, A. Misra, M. K. Daga, M. Varma, S. Jasuja, S. Upadhyaya, R. R. Kasliwal, M. Bansal, R. Mehrotra, A. Jain, K. K. Talwar, R. Rajput, A. Pradhan, S. Seth, D. Kapoor, R. P. Melinkeri, S. Ramakrishnan, N. N. Khanna, R. Khadgawat, S. Puri, A. Shaikh, N. Kovalipati, N. Bordoloi, A. H. Zargar, R. K. Agarwal, A. Rastogi, M. Chag, D. Prabhakar, S. K. Mathur, H. Rehan, P. K. Sahoo, A. Dutta, A. Sharma, A. K. Pancholia, K. U. Natarajan, A. Mishra & K. Singh. (2017) Lipid Association of India (LAI) expert consensus statement on management of dyslipidaemia in Indians 2017: part 2. Clinical Lipidology 12:1, pages 56-109.
Read now
Read now
Howard S. Weintraub. (2014) Overview of Prescription Omega-3 Fatty Acid Products for Hypertriglyceridemia. Postgraduate Medicine 126:7, pages 7-18.
Read now
Read now
Ichiro Tatsuno. (2014) Omega-3 polyunsaturated fatty acids and cardiovascular disease: an emphasis on omega-3-acid ethyl esters 90 for the treatment of hypertriglyceridemia. Expert Review of Cardiovascular Therapy 12:11, pages 1261-1268.
Read now
Read now
Michael H Davidson, Alyssa K Phillips, Douglas Kling & Kevin C Maki. (2014) Addition of omega-3 carboxylic acids to statin therapy in patients with persistent hypertriglyceridemia. Expert Review of Cardiovascular Therapy 12:9, pages 1045-1054.
Read now
Read now
Kevin C Maki, Sylvia P Poulos, Alyssa K Phillips & Andrea L Lawless. (2014) Prescription omega-3 carboxylic acids for the treatment of severe hypertriglyceridemia. Clinical Lipidology 9:4, pages 399-406.
Read now
Read now
Terry A Jacobson. (2014) Perspectives on a new prescription omega-3 fatty acid, icosapent ethyl, for hypertriglyceridemia. Clinical Lipidology 9:2, pages 149-161.
Read now
Read now
Nils Ewald. (2013) Hypertriglyceridemia-induced acute pancreatitis. Clinical Lipidology 8:5, pages 587-594.
Read now
Read now
Christie M Ballantyne, Rene A Braeckman & Paresh N Soni. (2013)
Icosapent ethyl for the treatment of hypertriglyceridemia. Expert Opinion on Pharmacotherapy 14:10, pages 1409-1416.
Read now
Read now
Julian P Halcox. (2013) Cardiovascular risk and lipid management beyond statin therapy: the potential role of omega–3 polyunsaturated fatty acid ethyl esters. Clinical Lipidology 8:3, pages 329-344.
Read now
Read now
Terry A Jacobson. (2012) A new pure ω-3 eicosapentaenoic acid ethyl ester (AMR101) for the management of hypertriglyceridemia: the MARINE trial. Expert Review of Cardiovascular Therapy 10:6, pages 687-695.
Read now
Read now
Niamh Phelan & James Gibney. (2012) What is the potential role of polyunsaturated fatty acids in controlling dyslipidemia in patients with polycystic ovary syndrome?. Clinical Lipidology 7:1, pages 5-8.
Read now
Read now
Thomas D Dayspring. (2011) Understanding hypertriglyceridemia in women: clinical impact and management with prescription omega-3-acid ethyl esters. International Journal of Women's Health 3, pages 87-97.
Read now
Read now
Matilda Florentin, Evangelos N Liberopoulos, Dimitri P Mikhailidis & Moses S Elisaf. (2011) Emerging options in the treatment of dyslipidemias: a bright future?. Expert Opinion on Emerging Drugs 16:2, pages 247-270.
Read now
Read now
Giacomo Levantesi, Maria Giuseppina Silletta & Roberto Marchioli. (2010) Uses and benefits of omega-3 ethyl esters in patients with cardiovascular disease. Journal of Multidisciplinary Healthcare 3, pages 79-96.
Read now
Read now
Kamal S. Hassan, Shadi K. Hassan, Ehsan G. Hijazi & Khalid O. Khazim. (2010) Effects of omega-3 on lipid profile and inflammation markers in peritoneal dialysis patients. Renal Failure 32:9, pages 1031-1035.
Read now
Read now
Rakesh K Sharma, Vibhuti N Singh & Hanumanth K Reddy. (2009) Thinking beyond low-density lipoprotein cholesterol: strategies to further reduce cardiovascular risk. Vascular Health and Risk Management 5, pages 793-799.
Read now
Read now
Carl J. Lavie. (2009) Review of Effect of Prescription Omega-3 Fatty Acids on Body Weight. Postgraduate Medicine 121:6, pages 200-202.
Read now
Read now
Harold E. Bays, Kevin C. Maki, Ralph T. Doyle & Evan Stein. (2009) The Effect of Prescription Omega-3 Fatty Acids on Body Weight after 8 to 16 Weeks of Treatment for Very High Triglyceride Levels. Postgraduate Medicine 121:5, pages 145-150.
Read now
Read now
Kevin Maki1, Mary Dicklin, Andrea Lawless & Matthew Reeves. (2009) Omega-3 fatty acids for the treatment of elevated triglycerides. Clinical Lipidology 4:4, pages 425-437.
Read now
Read now
Richard Sadovsky, Nancy Collins, P. Tighe Ann, Richard S. Safeer, Charlene M. Morris & Stephen A. Brunton. (2008) Dispelling the Myths About Omega-3 Fatty Acids. Postgraduate Medicine 120:2, pages 92-100.
Read now
Read now
Articles from other publishers (155)
Muhammed Ibrahim Erbay, Norma Nicole Gamarra Valverde, Parth Patel, Hasan Selcuk Ozkan, Andre Wilson, Suvam Banerjee, Aydan Babazade, Valeria Londono, Aayushi Sood & Rahul Gupta. (2024) Fish Oil Derivatives in Hypertriglyceridemia: Mechanism and Cardiovascular Prevention: What Do Studies Say?. Current Problems in Cardiology 49:1, pages 102066.
Crossref
Crossref
Amir Hossein Moridpour, Masomeh Goodarzi, Zeynab Kavyani, Negarsadat Nademi, Maziar Daneshvar, Vali Musazadeh & Amir Hossein Faghfouri. (2023) Application of Flaxseed as an Effective Approach for Improving Lipid Profile Parameters: An Updated Systematic Review and Meta-analysis of Randomized Controlled Trials. PharmaNutrition, pages 100366.
Crossref
Crossref
Bambang Dwiputra, Anwar Santoso, Budhi Setianto Purwowiyoto, Basuni Radi, Bashar Adi Wahyu Pandhita, Serlie Fatrin & Ade Meidian Ambari. (2023) Current Evidence and Future Directions of Omega-3 Supplementation and Cardiovascular Disease Risk. International Journal of Angiology.
Crossref
Crossref
Mai Elsheikh, Doaa El Amrousy, Heba El-Mahdy, Heba Dawoud, Ahmed Harkan & Amany El-Barky. (2023) Lipid profile after omega-3 supplementation in neonates with intrauterine growth retardation: a randomized controlled trial. Pediatric Research 94:4, pages 1503-1509.
Crossref
Crossref
Johnny Laupsa-Borge, Elise Grytten, Pavol Bohov, Bodil Bjørndal, Elin Strand, Jon Skorve, Jan Erik Nordrehaug, Rolf K. Berge, Espen Rostrup, Gunnar Mellgren, Simon N. Dankel & Ottar K. Nygård. (2023) Sex-specific responses in glucose-insulin homeostasis and lipoprotein-lipid components after high-dose supplementation with marine n-3 PUFAs in abdominal obesity: a randomized double-blind crossover study. Frontiers in Nutrition 10.
Crossref
Crossref
Luigi Barrea, Claudia Vetrani, Ludovica Verde, Evelyn Frias-Toral, Florencia Ceriani, Simona Cernea, Annamaria Docimo, Chiara Graziadio, Devjit Tripathy, Silvia Savastano, Annamaria Colao & Giovanna Muscogiuri. (2023) Comprehensive Approach to Medical Nutrition Therapy in Patients with Type 2 Diabetes Mellitus: From Diet to Bioactive Compounds. Antioxidants 12:4, pages 904.
Crossref
Crossref
Duygu Ağagündüz, Mehmet Arif Icer, Ozge Yesildemir, Tevfik Koçak, Emine Kocyigit & Raffaele Capasso. (2023) The roles of dietary lipids and lipidomics in gut-brain axis in type 2 diabetes mellitus. Journal of Translational Medicine 21:1.
Crossref
Crossref
Sarvin Sanaie. (2023) Dietary Supplements: Boon or Bane?. International Journal of Drug Research in Clinics 1, pages e16.
Crossref
Crossref
Vidya Sankarapandian, Bhuvaneshwari Jothirajan, Sumithra Pasumalai Arasu, Sumaliny Subramaniam & Balu Alagar Venmathi Maran. 2023. Marine Biotechnology: Applications in Food, Drugs and Energy. Marine Biotechnology: Applications in Food, Drugs and Energy
189
208
.
Cristiane Almeida Soares Cattani & Renata Heck. 2023. Dermatology in Public Health Environments. Dermatology in Public Health Environments
1041
1052
.
Ira J. Goldberg, Jana Gjini & Edward A. Fisher. (2022) Big Fish or No Fish; Eicosapentaenoic Acid and Cardiovascular Disease. Endocrinology and Metabolism Clinics of North America 51:3, pages 625-633.
Crossref
Crossref
Branko Ravić, Jasmina Debeljak-Martacić, Biljana Pokimica, Nevena Vidović, Slavica Ranković, Marija Glibetić, Predrag Stepanović & Tamara Popović. (2022) The Effect of Fish Oil-Based Foods on Lipid and Oxidative Status Parameters in Police Dogs. Biomolecules 12:8, pages 1092.
Crossref
Crossref
Jiawei Zhou, Lixin Cai, Senmiao Ni, Zihang Zhong, Min Yang, Hao Yu, Yang Zhao, Pengcheng Xun & Jianling Bai. (2021) Associations of dietary PUFA with dyslipidaemia among the US adults: the findings from National Health and Nutrition Examination Survey (NHANES) 2009–2016. British Journal of Nutrition 127:9, pages 1386-1394.
Crossref
Crossref
Peter P. Toth, M. John Chapman, Klaus G. Parhofer & John R. Nelson. (2022) Differentiating EPA from EPA/DHA in cardiovascular risk reduction. American Heart Journal Plus: Cardiology Research and Practice 17, pages 100148.
Crossref
Crossref
Fabrizio Ceraudo, Giovanna Caparello, Angelo Galluccio, Ennio Avolio, Giuseppina Augimeri, Daniela De Rose, Adele Vivacqua, Catia Morelli, Ines Barone, Stefania Catalano, Cinzia Giordano, Diego Sisci & Daniela Bonofiglio. (2022) Impact of Mediterranean Diet Food Choices and Physical Activity on Serum Metabolic Profile in Healthy Adolescents: Findings from the DIMENU Project. Nutrients 14:4, pages 881.
Crossref
Crossref
Joana Érica Lima Rocha, Mariely Mendes Furtado, Renato Sampaio Mello Neto, Ana Victória da Silva Mendes, Ana Karolinne da Silva Brito, José Otávio Carvalho Sena de Almeida, Emerson Iuri Rodrigues Queiroz, José Vinícius de Sousa França, Maísa Guimarães Silva Primo, Ana Lina de Carvalho Cunha Sales, Andreanne Gomes Vasconcelos, Wanessa Felix Cabral, Selma Aparecida Souza Kückelhaus, José Roberto de Souza de Almeida Leite, Ana Karina Marques Fortes Lustosa, Massimo Lucarini, Alessandra Durazzo, Daniel Dias Rufino Arcanjo & Maria do Carmo de Carvalho e Martins. (2022) Effects of Fish Oil Supplementation on Oxidative Stress Biomarkers and Liver Damage in Hypercholesterolemic Rats. Nutrients 14:3, pages 426.
Crossref
Crossref
Savina Nodari & Francesco Fioretti. 2022. Fatty Acids - From Biosynthesis to Human Health [Working Title]. Fatty Acids - From Biosynthesis to Human Health [Working Title].
Venkat S Manubolu, Matthew J Budoff & Suvasini Lakshmanan. (2022) Multimodality Imaging Trials Evaluating the Impact of Omega-3 Fatty Acids on Coronary Artery Plaque Characteristics and Burden. Heart International 16:1, pages 2.
Crossref
Crossref
Charlotte C.J.R. Michielsen, Roland W.J. Hangelbroek, Marjolijn C.E. Bragt, Elwin R. Verheij, Suzan Wopereis, Ronald P. Mensink & Lydia A. Afman. (2021) Comparative Analysis of the Effects of Fish Oil and Fenofibrate on Plasma Metabolomic Profiles in Overweight and Obese Individuals. Molecular Nutrition & Food Research 66:2.
Crossref
Crossref
Ali. M. Atallah & Faryal. F. Hussein. (2021) Study of the Healthy Effects of Different Fat Ratios Mixtures of Omega-3 to Omega-6 in Male Mice with Alloxan-Induced Diabetes. Tikrit journal for agricultural sciences 21:4, pages 129-138.
Crossref
Crossref
Julia T. Stadler & Gunther Marsche. (2021) Dietary Strategies to Improve Cardiovascular Health: Focus on Increasing High-Density Lipoprotein Functionality. Frontiers in Nutrition 8.
Crossref
Crossref
Bret M. Rust, Susan K. Raatz, Shanon L. Casperson, Sara E. Duke & Matthew J. Picklo. (2021) Dietary Fat Chain Length, Saturation, and PUFA Source Acutely Affect Diet-Induced Thermogenesis but Not Satiety in Adults in a Randomized, Crossover Trial. Nutrients 13:8, pages 2615.
Crossref
Crossref
Elise Grytten, Johnny Laupsa-Borge, Pavol Bohov, Bodil Bjørndal, Elin Strand, Jon Skorve, Jan Erik Nordrehaug, Rolf K. Berge, Espen Rostrup, Gunnar Mellgren, Simon N. Dankel & Ottar K. Nygård. (2021) Changes in lipoprotein particle subclasses, standard lipids, and apolipoproteins after supplementation with n-3 or n-6 PUFAs in abdominal obesity: A randomized double-blind crossover study. Clinical Nutrition 40:5, pages 2556-2575.
Crossref
Crossref
Dominika Jamioł-Milc, Jowita Biernawska, Magdalena Liput, Laura Stachowska & Zdzisław Domiszewski. (2021) Seafood Intake as a Method of Non-Communicable Diseases (NCD) Prevention in Adults. Nutrients 13:5, pages 1422.
Crossref
Crossref
Sie Chong Doris Lau, C-Khai Loh & Hamidah Alias. (2021) Case Report: The Use of Intravenous SMOFlipid Infusion to Treat Severe Asparaginase-Induced Hypertriglyceridemia in Two Pediatric Acute Lymphoblastic Leukemia Patients. Frontiers in Pediatrics 9.
Crossref
Crossref
Tewodros Shibabaw. (2020) Omega-3 polyunsaturated fatty acids: anti-inflammatory and anti-hypertriglyceridemia mechanisms in cardiovascular disease. Molecular and Cellular Biochemistry 476:2, pages 993-1003.
Crossref
Crossref
Meysam Zarezadeh, Amir Hossein Faghfouri, Nima Radkhah, Elaheh Foroumandi, Masoud Khorshidi, Ahmadreza Rasouli, Mahtab Zarei, Niyaz Mohammadzadeh Honarvar, Nazanin Hazhir Karzar & Mehrangiz Ebrahimi Mamaghani. (2020) Spirulina supplementation and anthropometric indices: A systematic review and meta‐analysis of controlled clinical trials. Phytotherapy Research 35:2, pages 577-586.
Crossref
Crossref
Jae-Myung Kim & Man-Seok Park. 2021. Stroke Revisited: Dyslipidemia in Stroke. Stroke Revisited: Dyslipidemia in Stroke
111
123
.
Jan Borén & Marja-Riitta Taskinen. 2022. Prevention and Treatment of Atherosclerosis. Prevention and Treatment of Atherosclerosis
133
156
.
Youssef El-Shattor, Saadia M. Aly, Ghada A. Abo-Elwafa, Seham S. Kassem, Ibrahim H. Badaw, Wafaa K. Bahgaat & Mervat I. Foda. (2020) Chemical and Nutritional Evaluation of Novel White Soft Cheese Prepared by Nano-Fortified Interesterified Olein: Stearin Vegetable Butter. International Journal of Dairy Science 15:4, pages 161-168.
Crossref
Crossref
Ahmad Jayedi & Sakineh Shab-Bidar. (2020) Fish Consumption and the Risk of Chronic Disease: An Umbrella Review of Meta-Analyses of Prospective Cohort Studies. Advances in Nutrition 11:5, pages 1123-1133.
Crossref
Crossref
Mahbobe Rashidi, Mohammad Rashidmayvan, Somayeh Alboativi & Fereshteh Amiri. (2020) The effect of fish oil supplements on serum levels of albumin, lipid profiles, and kidney function in patients with hypoalbuminemia admitted to an intensive care unit, Randomized controlled trial. PharmaNutrition 13, pages 100197.
Crossref
Crossref
Daisuke Hishikawa, Keisuke Yanagida, Katsuyuki Nagata, Ayumi Kanatani, Yoshiko Iizuka, Fumie Hamano, Megumi Yasuda, Tadashi Okamura, Hideo Shindou & Takao Shimizu. (2020) Hepatic Levels of DHA-Containing Phospholipids Instruct SREBP1-Mediated Synthesis and Systemic Delivery of Polyunsaturated Fatty Acids. iScience 23:9, pages 101495.
Crossref
Crossref
Claire Mayer, Martine Côme, Vincent Blanckaert, Graziella Chini Zittelli, Cecilia Faraloni, Hassan Nazih, Khadija Ouguerram, Virginie Mimouni & Benoît Chénais. (2020) Effect of Carotenoids from Phaeodactylum tricornutum on Palmitate-Treated HepG2 Cells. Molecules 25:12, pages 2845.
Crossref
Crossref
Simona Serini & Gabriella Calviello. (2020) Omega-3 PUFA Responders and Non-Responders and the Prevention of Lipid Dysmetabolism and Related Diseases. Nutrients 12:5, pages 1363.
Crossref
Crossref
Bernard Cuenoud, Isabelle Rochat, Maria Gosoniu, Lenaick Dupuis, Evan Berk, Anke Jaudszus, Jochen Mainz, Gaudenz Hafen, Maurice Beaumont & Cristina Cruz-Hernandez. (2020) Monoacylglycerol Form of Omega-3s Improves Its Bioavailability in Humans Compared to Other Forms. Nutrients 12:4, pages 1014.
Crossref
Crossref
Zhi-Hong Yang, Marcelo Amar, Maureen Sampson, Amber B. Courville, Alexander V. Sorokin, Scott M. Gordon, Angel M. Aponte, Michael Stagliano, Martin P. Playford, Yi-Ping Fu, Shanna Yang, Nehal N. Mehta & Alan T. Remaley. (2020) Comparison of Omega-3 Eicosapentaenoic Acid Versus Docosahexaenoic Acid-Rich Fish Oil Supplementation on Plasma Lipids and Lipoproteins in Normolipidemic Adults. Nutrients 12:3, pages 749.
Crossref
Crossref
Yasuhiro Watanabe & Ichiro Tatsuno. (2020) Prevention of Cardiovascular Events with Omega-3 Polyunsaturated Fatty Acids and the Mechanism Involved. Journal of Atherosclerosis and Thrombosis 27:3, pages 183-198.
Crossref
Crossref
Guohua Li, Xinpei Wang, Hongyan Yang, Pengfei Zhang, Fangqin Wu, Yunchu Li, Yingjie Zhou, Xing Zhang, Heng Ma, Wei Zhang & Jia Li. (2020) α-Linolenic acid but not linolenic acid protects against hypertension: critical role of SIRT3 and autophagic flux. Cell Death & Disease 11:2.
Crossref
Crossref
D Fithriani, D Ambarwaty & Nurhayati. (2020) Identification of bioactive compounds from Nannochloropsis sp.. IOP Conference Series: Earth and Environmental Science 404:1, pages 012064.
Crossref
Crossref
Denny Joseph Manual Kollareth, Chuchun L. Chang, Hylde Zirpoli & Richard J. Deckelbaum. 2020. Lipid Signaling and Metabolism. Lipid Signaling and Metabolism
427
453
.
Veronica Ghini, Leonardo Tenori, Francesco Capozzi, Claudio Luchinat, Achim Bub, Corinne Malpuech-Brugere, Caroline Orfila, Luigi Ricciardiello & Alessandra Bordoni. (2019) DHA-Induced Perturbation of Human Serum Metabolome. Role of the Food Matrix and Co-Administration of Oat β-glucan and Anthocyanins. Nutrients 12:1, pages 86.
Crossref
Crossref
Gagan D. Flora & Manasa K. Nayak. (2019) A Brief Review of Cardiovascular Diseases, Associated Risk Factors and Current Treatment Regimes. Current Pharmaceutical Design 25:38, pages 4063-4084.
Crossref
Crossref
María Rodríguez, Pilar G. Rebollar, Simona Mattioli & Cesare Castellini. (2019) n-3 PUFA Sources (Precursor/Products): A Review of Current Knowledge on Rabbit. Animals 9:10, pages 806.
Crossref
Crossref
Chen He, Jun Cao, Xin Jiang, Chunyan Wen, Xinpeng Bai & Chuan Li. (2019)
Fatty Acid Profiles of Triacylglycerols and Phospholipids of Sea‐Cage Cultured
Trachinotus blochii
: A Comparative Study of Head, Viscera, Skin, Bone, and Muscle
. Journal of Food Science 84:3, pages 650-658.
Crossref
Crossref
Yohei Kawasaki, Yoshihiro Iwahori, Yosuke Chiba, Hiroyuki Mitsumoto, Tomoe Kawasaki, Sumiko Fujita & Yoshinori Takahashi. (2019) Efficacy of DHA and EPA on Serum Triglyceride Levels of Healthy Participants: Systematic Review. International Journal of Nutrition 3:2, pages 22-40.
Crossref
Crossref
Merle Myerson. 2019. Cardiovascular Care in Patients With HIV. Cardiovascular Care in Patients With HIV
23
45
.
Charles J. Ferro, Patrick B. Mark, Mehmet Kanbay, Pantelis Sarafidis, Gunnar H. Heine, Patrick Rossignol, Ziad A. Massy, Francesca Mallamaci, Jose M. Valdivielso, Jolanta Malyszko, Marianne C. Verhaar, Robert Ekart, Raymond Vanholder, Gerard London, Alberto Ortiz & Carmine Zoccali. (2018) Lipid management in patients with chronic kidney disease. Nature Reviews Nephrology 14:12, pages 727-749.
Crossref
Crossref
Reheman Adili, Megan Hawley & Michael Holinstat. (2018) Regulation of platelet function and thrombosis by omega-3 and omega-6 polyunsaturated fatty acids. Prostaglandins & Other Lipid Mediators 139, pages 10-18.
Crossref
Crossref
Cassandra Sparkes, Robert Gibson, Andrew Sinclair, Paul Else & Barbara Meyer. (2018) Effect of Low Dose Docosahexaenoic Acid-Rich Fish Oil on Plasma Lipids and Lipoproteins in Pre-Menopausal Women: A Dose–Response Randomized Placebo-Controlled Trial. Nutrients 10:10, pages 1460.
Crossref
Crossref
Carla Harris, Andrea von Berg, Dietrich Berdel, Carl-Peter Bauer, Tamara Schikowski, Sibylle Koletzko, Joachim Heinrich, Holger Schulz & Marie Standl. (2018) Association of Dietary Fatty Acids with Blood Lipids is Modified by Physical Activity in Adolescents: Results from the GINIplus and LISA Birth Cohort Studies. Nutrients 10:10, pages 1372.
Crossref
Crossref
Rohith N. Thota, Jessica J. A. Ferguson, Kylie A. Abbott, Cintia B. Dias & Manohar L. Garg. (2018)
Science behind the cardio-metabolic benefits of omega-3 polyunsaturated fatty acids: biochemical effects
vs
. clinical outcomes
. Food & Function 9:7, pages 3576-3596.
Crossref
Crossref
Antonio Capurso, Gaetano Crepaldi & Cristiano CapursoAntonio Capurso, Gaetano Crepaldi & Cristiano Capurso. 2018. Benefits of the Mediterranean Diet in the Elderly Patient. Benefits of the Mediterranean Diet in the Elderly Patient
325
352
.
Petter-Arnt Hals, Xiaoli Wang & Yong-Fu Xiao. (2017) Effects of a purified krill oil phospholipid rich in long-chain omega-3 fatty acids on cardiovascular disease risk factors in non-human primates with naturally occurring diabetes type-2 and dyslipidemia. Lipids in Health and Disease 16:1.
Crossref
Crossref
Yu-Xiao Zou, Teng-Gen Hu, Ying Shi, Jun Liu, Li-Xia Mu, Yang Xiao & Sen-Tai Liao. (2017) Establishment of a model to evaluate the nutritional quality of Bombyx mori Linnaeus (Lepidoptera, Bombycidae) pupae lipid based on principal components. Journal of Asia-Pacific Entomology 20:4, pages 1364-1371.
Crossref
Crossref
Gina E. Nam, Seung‐Kwon Myung & Yoon‐Jung Choi. (2017) Use of Omega‐3 Fatty Acid Supplements Has Insufficient Clinical Evidence for Treatment of Hypertriglyceridemia: A Meta‐Analysis of Randomized, Double‐Blind, Placebo‐Controlled Trials. European Journal of Lipid Science and Technology 119:12.
Crossref
Crossref
Javier S. Perona. (2017) Membrane lipid alterations in the metabolic syndrome and the role of dietary oils. Biochimica et Biophysica Acta (BBA) - Biomembranes 1859:9, pages 1690-1703.
Crossref
Crossref
Yuxiao Zou, Tenggen Hu, Ying Shi, Sentai Liao, Jun Liu, Lixia Mu & C-Y Oliver Chen. (2017) Silkworm pupae oil exerts hypercholesterolemic and antioxidant effects in high-cholesterol diet-fed rats. Journal of the Science of Food and Agriculture 97:7, pages 2050-2056.
Crossref
Crossref
Kevin C. Maki, Colleen Johns, William S. Harris, Mark Puder, Steven D. Freedman, Thorsteinn Thorsteinsson, Ahmed Daak, Adrian L. Rabinowicz & Frederick D. Sancilio. (2017) Bioequivalence Demonstration for Ω-3 Acid Ethyl Ester Formulations: Rationale for Modification of Current Guidance. Clinical Therapeutics 39:3, pages 652-658.
Crossref
Crossref
Dean G. Karalis. (2016) A Review of Clinical Practice Guidelines for the Management of Hypertriglyceridemia: A Focus on High Dose Omega-3 Fatty Acids. Advances in Therapy 34:2, pages 300-323.
Crossref
Crossref
Kevin C. Maki, George Bobotas, Mary R. Dicklin, Margie Huebner & William F. Keane. (2017) Effects of MAT9001 containing eicosapentaenoic acid and docosapentaenoic acid, compared to eicosapentaenoic acid ethyl esters, on triglycerides, lipoprotein cholesterol, and related variables. Journal of Clinical Lipidology 11:1, pages 102-109.
Crossref
Crossref
James Backes, Deborah Anzalone, Daniel Hilleman & Julia Catini. (2016) The clinical relevance of omega-3 fatty acids in the management of hypertriglyceridemia. Lipids in Health and Disease 15:1.
Crossref
Crossref
Valérie Lamantia, Allan Sniderman & May Faraj. (2016) Nutritional management of hyperapoB. Nutrition Research Reviews 29:2, pages 202-233.
Crossref
Crossref
Kwang Kon Koh, Pyung Chun Oh, Ichiro Sakuma, Yonghee Lee, Seung Hwan Han & Eak Kyun Shin. (2016) Vascular and metabolic effects of omega-3 fatty acids combined with fenofibrate in patients with hypertriglyceridemia. International Journal of Cardiology 221, pages 342-346.
Crossref
Crossref
Christie M. Ballantyne, Harold E. Bays, Sephy Philip, Ralph T. DoyleJr.Jr., Rene A. Braeckman, William G. Stirtan, Paresh N. Soni & Rebecca A. Juliano. (2016) Icosapent ethyl (eicosapentaenoic acid ethyl ester): Effects on remnant-like particle cholesterol from the MARINE and ANCHOR studies. Atherosclerosis 253, pages 81-87.
Crossref
Crossref
Christie M. Ballantyne, Harold E. Bays, Rene A. Braeckman, Sephy Philip, William G. Stirtan, Ralph T. DoyleJr.Jr., Paresh N. Soni & Rebecca A. Juliano. (2016) Icosapent ethyl (eicosapentaenoic acid ethyl ester): Effects on plasma apolipoprotein C-III levels in patients from the MARINE and ANCHOR studies. Journal of Clinical Lipidology 10:3, pages 635-645.e1.
Crossref
Crossref
Merle Myerson. (2016) Lipid Management in Human Immunodeficiency Virus. Endocrinology and Metabolism Clinics of North America 45:1, pages 141-169.
Crossref
Crossref
J. J. A. Ferguson, C. B. Dias & M. L. Garg. 2016. Omega-3 Fatty Acids. Omega-3 Fatty Acids
67
78
.
Anjeza PashajMengna XiaRégis Moreau. (2015) α-Lipoic acid as a triglyceride-lowering nutraceutical. Canadian Journal of Physiology and Pharmacology 93:12, pages 1029-1041.
Crossref
Crossref
Ichiro Tatsuno, Kentarou Kudou & Tomoya Kagawa. (2015)
Effect of
TAK
‐085 on Low‐density Lipoprotein Particle Size in Patients with Hypertriglyceridemia: A Double‐blind Randomized Clinical Study
. Cardiovascular Therapeutics 33:6, pages 317-323.
Crossref
Crossref
Dahyun Hwang, Sung-Pil Jo, Jiyun Lee, Jeong-Keun Kim, Ki-Hyun Kim & Young-Hee Lim. (2015) Antihyperlipidaemic effects of oxyresveratrol-containing Ramulus mori ethanol extract in rats fed a high-cholesterol diet. Journal of Functional Foods 19, pages 353-362.
Crossref
Crossref
H. Adamski & D. Bligny. (2015) Xantomas. EMC - Dermatología 49:4, pages 1-13.
Crossref
Crossref
Karen R. Sando & Michelle Knight. (2015) Nonstatin Therapies for Management of Dyslipidemia: A Review. Clinical Therapeutics 37:10, pages 2153-2179.
Crossref
Crossref
Kenneth M. Borow, John R. Nelson & R. Preston Mason. (2015) Biologic plausibility, cellular effects, and molecular mechanisms of eicosapentaenoic acid (EPA) in atherosclerosis. Atherosclerosis 242:1, pages 357-366.
Crossref
Crossref
Merle Myerson, Carlos Malvestutto & Judith A. Aberg. (2015) Management of lipid disorders in patients living with HIV. The Journal of Clinical Pharmacology 55:9, pages 957-974.
Crossref
Crossref
S. Marlene Grenon, Christopher D. Owens, Emily V. Nosova, Millie Hughes‐Fulford, Hugh F. Alley, Karen Chong, Sandra Perez, Priscilla K. Yen, John Boscardin, Jason Hellmann, Matthew Spite & Michael S. Conte. (2015) Short‐Term, High‐Dose Fish Oil Supplementation Increases the Production of Omega‐3 Fatty Acid–Derived Mediators in Patients With Peripheral Artery Disease (the OMEGA‐PAD I Trial). Journal of the American Heart Association 4:8.
Crossref
Crossref
Harold E. BaysChristie M. BallantyneRene A. BraeckmanWilliam G. StirtanRalph T. DoyleJrJrSephy PhilipParesh N. SoniRebecca A. Juliano. (2015) Icosapent Ethyl (Eicosapentaenoic Acid Ethyl Ester): Effects Upon High-Sensitivity C-Reactive Protein and Lipid Parameters in Patients With Metabolic Syndrome. Metabolic Syndrome and Related Disorders 13:6, pages 239-247.
Crossref
Crossref
Patty W. Siri-TarinoSally ChiuNathalie Bergeron & Ronald M. Krauss. (2015) Saturated Fats Versus Polyunsaturated Fats Versus Carbohydrates for Cardiovascular Disease Prevention and Treatment. Annual Review of Nutrition 35:1, pages 517-543.
Crossref
Crossref
Merle Myerson. (2015) Lipid Management in Human Immunodeficiency Virus. Cardiology Clinics 33:2, pages 277-298.
Crossref
Crossref
Yehuda Handelsman, Zachary T. Bloomgarden, George Grunberger, Guillermo Umpierrez, Robert S. Zimmerman, Timothy S. Bailey, Lawrence Blonde, George A. Bray, A. Jay Cohen, Samuel Dagogo-Jack, Jaime A. Davidson, Daniel Einhorn, Om P. Ganda, Alan J. Garber, W. Timothy Garvey, Robert R. Henry, Irl B. Hirsch, Edward S. Horton, Daniel L. Hurley, Paul S. Jellinger, Lois Jovanovič, Harold E. Lebovitz, Derek LeRoith, Philip Levy, Janet B. McGill, Jeffrey I. Mechanick, Jorge H. Mestman, Etie S. Moghissi, Eric A. Orzeck, Rachel Pessah-Pollack, Paul D. Rosenblit, Aaron I. Vinik, Kathleen Wyne & Farhad Zangeneh. (2015) American Association Of Clinical Endocrinologists And American College Of Endocrinology -Clinical Practice Guidelines For Developing A Diabetes Mellitus Comprehensive Care Plan – 2015. Endocrine Practice 21, pages 1-87.
Crossref
Crossref
Sanaz Gholamhosseini, Ebrahim Nematipour, Abolghassem Djazayery, Mohammad Hassan Javanbakht, Fariba Koohdani, Mahnaz Zareei & Mahmoud Djalali. (2015) ω-3 fatty acid differentially modulated serum levels of IGF1 and IGFBP3 in men with CVD: A randomized, double-blind placebo-controlled study. Nutrition 31:3, pages 480-484.
Crossref
Crossref
Alberto Krayyem Arbex, Vagner Rosa Bizarro, Julio Cesar Salles Santos, Lis Marina Mesquita Araújo, Ana Luísa Conceição de Jesus, Minelli Salles Alves Fernandes, Marcela Miranda Salles, Denise Rosso Tenório Wanderley Rocha & Aline Marcadenti. (2015) The Impact of the Essential Fatty Acids (EFA) in Human Health. Open Journal of Endocrine and Metabolic Diseases 05:07, pages 98-104.
Crossref
Crossref
Eric J. Brandt & Michael H. Davidson. 2015. Combination Therapy In Dyslipidemia. Combination Therapy In Dyslipidemia
45
64
.
Catherine Ouellette, Iwona Rudkowska, Simone Lemieux, Benoit Lamarche, Patrick Couture & Marie-Claude Vohl. (2014) Gene-diet interactions with polymorphisms of the MGLL gene on plasma low-density lipoprotein cholesterol and size following an omega-3 polyunsaturated fatty acid supplementation: a clinical trial. Lipids in Health and Disease 13:1.
Crossref
Crossref
Laskarina-Maria Korou, George Agrogiannis, Christos Koros, Efthimia Kitraki, Ioannis S. Vlachos, Irene Tzanetakou, Theodore Karatzas, Vasilios Pergialiotis, Dimitrios Dimitroulis & Despina N. Perrea. (2014) Impact of N-acetylcysteine and sesame oil on lipid metabolism and hypothalamic-pituitary-adrenal axis homeostasis in middle-aged hypercholesterolemic mice. Scientific Reports 4:1.
Crossref
Crossref
Pyung Chun Oh, Kwang Kon Koh, Ichiro Sakuma, Soo Lim, Yonghee Lee, Seungik Lee, Kyounghoon Lee, Seung Hwan Han & Eak Kyun Shin. (2014) Omega-3 fatty acid therapy dose-dependently and significantly decreased triglycerides and improved flow-mediated dilation, however, did not significantly improve insulin sensitivity in patients with hypertriglyceridemia. International Journal of Cardiology 176:3, pages 696-702.
Crossref
Crossref
Andreea Dragomir, Emila Rusu, Mihaela Posea & Gabriela Radulian. (2014) Decrease of Atherosclerosis Markers and Oxidative Stress After 1 Year Administration of Omega-3 Fatty Acids Supplements in Patients with Metabolic Syndrome. Romanian Journal of Diabetes Nutrition and Metabolic Diseases 21:3, pages 175-183.
Crossref
Crossref
Robert Fischer, Anne Konkel, Heidrun Mehling, Katrin Blossey, Andrej Gapelyuk, Niels Wessel, Clemens von Schacky, Ralf Dechend, Dominik N. Muller, Michael Rothe, Friedrich C. Luft, Karsten Weylandt & Wolf-Hagen Schunck. (2014) Dietary omega-3 fatty acids modulate the eicosanoid profile in man primarily via the CYP-epoxygenase pathway. Journal of Lipid Research 55:6, pages 1150-1164.
Crossref
Crossref
Léopold K. Fezeu, François Laporte, Emmanuelle Kesse-Guyot, Valentina A. Andreeva, Jacques Blacher, Serge Hercberg & Pilar Galan. (2014) Baseline Plasma Fatty Acids Profile and Incident Cardiovascular Events in the SU.FOL.OM3 Trial: The Evidence Revisited. PLoS ONE 9:4, pages e92548.
Crossref
Crossref
Pasquale Losurdo, Andrea Grillo, Emiliano Panizon, Gianluca Gortan Cappellari, Bruno Fabris, Moreno Bardelli, Gianni Biolo, Michela Zanetti & Renzo Carretta. (2013) Supplementation of Omega-3 Polyunsaturated Fatty Acids Prevents Increase in Arterial Stiffness After Experimental Menopause. Journal of Cardiovascular Pharmacology and Therapeutics 19:1, pages 114-120.
Crossref
Crossref
Hemalatha Rajkumar, Naseha Mahmood, Manoj Kumar, Sudarshan Reddy Varikuti, Hanumanth Reddy Challa & Shiva Prakash Myakala. (2014) Effect of Probiotic (VSL#3) and Omega-3 on Lipid Profile, Insulin Sensitivity, Inflammatory Markers, and Gut Colonization in Overweight Adults: A Randomized, Controlled Trial. Mediators of Inflammation 2014, pages 1-8.
Crossref
Crossref
Andrew J. Stewart Coats. (2013) Round table on “Current evidence and future perspectives on n−3 PUFA”. International Journal of Cardiology 170:2, pages S1-S2.
Crossref
Crossref
Angela Pirillo & Alberico Luigi Catapano. (2013) Omega-3 polyunsaturated fatty acids in the treatment of hypertriglyceridaemia. International Journal of Cardiology 170:2, pages S16-S20.
Crossref
Crossref
P.C. Manoria, H.K. Chopra, S.K. Parashar, A.L. Dutta, Brian Pinto, Ajit Mullasari & Samir Prajapati. (2013) The nuances of atherogenic dyslipidemia in diabetes: Focus on triglycerides and current management strategies. Indian Heart Journal 65:6, pages 683-690.
Crossref
Crossref
Ichiro Tatsuno, Yasushi Saito, Kentarou Kudou & Jun Ootake. (2013) Long-term safety and efficacy of TAK-085 in Japanese subjects with hypertriglyceridemia undergoing lifestyle modification: The omega-3 fatty acids randomized long-term (ORL) study. Journal of Clinical Lipidology 7:6, pages 615-625.
Crossref
Crossref
Rene A. Braeckman, Mehar S. Manku, Harold E. Bays, William G. Stirtan & Paresh N. Soni. (2013) Icosapent ethyl, a pure EPA omega-3 fatty acid: Effects on plasma and red blood cell fatty acids in patients with very high triglyceride levels (results from the MARINE study). Prostaglandins, Leukotrienes and Essential Fatty Acids 89:4, pages 195-201.
Crossref
Crossref
Muhammad Issa Khan, Faqir Muhammad Anjum, Muhammad Sohaib & Aysha Sameen. (2013) Tackling metabolic syndrome by functional foods. Reviews in Endocrine and Metabolic Disorders 14:3, pages 287-297.
Crossref
Crossref
Harold E. Bays, Peter P. Toth, Penny M. Kris-Etherton, Nicola Abate, Louis J. Aronne, W. Virgil Brown, J. Michael Gonzalez-Campoy, Steven R. Jones, Rekha Kumar, Ralph La Forge & Varman T. Samuel. (2013) Obesity, adiposity, and dyslipidemia: A consensus statement from the National Lipid Association. Journal of Clinical Lipidology 7:4, pages 304-383.
Crossref
Crossref
Ichiro Tatsuno, Yasushi Saito, Kentarou Kudou & Jun Ootake. (2013) Efficacy and safety of TAK-085 compared with eicosapentaenoic acid in Japanese subjects with hypertriglyceridemia undergoing lifestyle modification: The omega-3 fatty acids randomized double-blind (ORD) study. Journal of Clinical Lipidology 7:3, pages 199-207.
Crossref
Crossref
Kaisa M. Linderborg, Gunveen Kaur, Eliza Miller, Peter J. Meikle, Amy E. Larsen, Jacquelyn M. Weir, Anu Nuora, Christopher K. Barlow, Heikki P. Kallio, David Cameron-Smith & Andrew J. Sinclair. (2013) Postprandial metabolism of docosapentaenoic acid (DPA, 22:5n−3) and eicosapentaenoic acid (EPA, 20:5n−3) in humans. Prostaglandins, Leukotrienes and Essential Fatty Acids 88:4, pages 313-319.
Crossref
Crossref
Harold E. Bays, Christie M. Ballantyne, Rene A. Braeckman, William G. Stirtan & Paresh N. Soni. (2013) Icosapent Ethyl, a Pure Ethyl Ester of Eicosapentaenoic Acid: Effects on Circulating Markers of Inflammation from the MARINE and ANCHOR Studies. American Journal of Cardiovascular Drugs 13:1, pages 37-46.
Crossref
Crossref
Tiffany Nicholson, Haidar Khademi & Mohammed H. Moghadasian. (2013) The role of marine n-3 fatty acids in improving cardiovascular health: a review. Food & Function 4:3, pages 357.
Crossref
Crossref
James R. Taylor, Eric Dietrich & Jason G. Powell. (2013) New and Emerging Pharmacologic Therapies for Type 2 Diabetes, Dyslipidemia, and Obesity. Clinical Therapeutics 35:1, pages A3-A17.
Crossref
Crossref
J. Moreillon, R.G. Bowden & B. Shelmadine. 2013. Bioactive Food as Dietary Interventions for Arthritis and Related Inflammatory Diseases. Bioactive Food as Dietary Interventions for Arthritis and Related Inflammatory Diseases
393
404
.
R. Sharma, R.J. Moffatt, R.B. Singh & J. Katz. 2013. Bioactive Food as Dietary Interventions for Cardiovascular Disease. Bioactive Food as Dietary Interventions for Cardiovascular Disease
1
28
.
R. Sharma. 2013. Bioactive Food as Dietary Interventions for Cardiovascular Disease. Bioactive Food as Dietary Interventions for Cardiovascular Disease
465
489
.
Akhlaq A. FarooquiAkhlaq A. Farooqui. 2013. Metabolic Syndrome. Metabolic Syndrome
143
189
.
R. Morrone, N. D’Antona, D. Biondi, D. Lambusta & G. Nicolosi. (2012) Preparation of n-3 PUFAs ethyl esters by an efficient biocatalyzed solvent-free process. Journal of Molecular Catalysis B: Enzymatic 84, pages 173-176.
Crossref
Crossref
Harold E. Bays, Rene A. Braeckman, Christie M. Ballantyne, John J. Kastelein, James D. Otvos, William G. Stirtan & Paresh N. Soni. (2012) Icosapent ethyl, a pure EPA omega-3 fatty acid: Effects on lipoprotein particle concentration and size in patients with very high triglyceride levels (the MARINE study). Journal of Clinical Lipidology 6:6, pages 565-572.
Crossref
Crossref
Ganesan Murali, Ginger L. Milne, Corey D. Webb, Ann B. Stewart, Ryan P. McMillan, Brandon C. Lyle, Matthew W. Hulver & Viswanathan Saraswathi. (2012) Fish oil and indomethacin in combination potently reduce dyslipidemia and hepatic steatosis in LDLR −/− mice. Journal of Lipid Research 53:10, pages 2186-2197.
Crossref
Crossref
Esther M.M. Ooi, Alice H. Lichtenstein, John S. Millar, Margaret R. Diffenderfer, Stefania Lamon-Fava, Helen Rasmussen, Francine K. Welty, P. Hugh R. Barrett & Ernst J. Schaefer. (2012) Effects of Therapeutic Lifestyle Change diets high and low in dietary fish-derived FAs on lipoprotein metabolism in middle-aged and elderly subjects. Journal of Lipid Research 53:9, pages 1958-1967.
Crossref
Crossref
Kevin C. Maki, Harold E. Bays & Mary R. Dicklin. (2012) Treatment options for the management of hypertriglyceridemia: Strategies based on the best-available evidence. Journal of Clinical Lipidology 6:5, pages 413-426.
Crossref
Crossref
Jonathan Santas, Jordi Espadaler, Remedios Mancebo & Magda Rafecas. (2012) Selective in vivo effect of chitosan on fatty acid, neutral sterol and bile acid excretion: A longitudinal study. Food Chemistry 134:2, pages 940-947.
Crossref
Crossref
Marita M Neville, J Geppert, Y Min, G Grimble, Michael A Crawford & K Ghebremeskel. (2013) Dietary fat intake, body composition and blood lipids of university men and women. Nutrition and Health 21:3, pages 173-185.
Crossref
Crossref
Changting Xiao & Gary F. Lewis. (2012) Regulation of chylomicron production in humans. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 1821:5, pages 736-746.
Crossref
Crossref
N Moghadasian & Mohammed EskinChantal Bassett, Richelle McCullough, Justin Deniset, rea Edel, rew Francis, Delfin Rodriguez-Leyva, Mirna Chahine & Grant Pierce. 2012. Functional Foods and Cardiovascular Disease. Functional Foods and Cardiovascular Disease
1
28
.
Kwang Kon Koh, Michael J. Quon, Kwen-Chul Shin, Soo Lim, Yonghee Lee, Ichiro Sakuma, Kyounghoon Lee, Seung Hwan Han & Eak Kyun Shin. (2012) Significant differential effects of omega-3 fatty acids and fenofibrate in patients with hypertriglyceridemia. Atherosclerosis 220:2, pages 537-544.
Crossref
Crossref
KEVIN SERRE & MUHAMMAD BAYU SASONGKO. (2011) Modifiable Lifestyle and Environmental Risk Factors Affecting the Retinal Microcirculation. Microcirculation 19:1, pages 29-36.
Crossref
Crossref
Terry A. Jacobson, Sara B. Glickstein, Jonathan D. Rowe & Paresh N. Soni. (2012) Effects of eicosapentaenoic acid and docosahexaenoic acid on low-density lipoprotein cholesterol and other lipids: A review. Journal of Clinical Lipidology 6:1, pages 5-18.
Crossref
Crossref
Barry S. Peters, Anthony S. Wierzbicki, Graeme Moyle, Devaki Nair & Norbert Brockmeyer. (2012) The Effect of a 12-Week Course of Omega-3 Polyunsaturated Fatty Acids on Lipid Parameters in Hypertriglyceridemic Adult HIV-infected Patients Undergoing HAART: A Randomized, Placebo-Controlled Pilot Trial. Clinical Therapeutics 34:1, pages 67-76.
Crossref
Crossref
William Jon Meadus, Pascale Duff, Dave Rolland, Jennifer Lynn Aalhus, Bethany Uttaro & Michael Edward Russell Dugan. (2011) Feeding docosahexaenoic acid to pigs reduces blood triglycerides and induces gene expression for fat oxidation. Canadian Journal of Animal Science 91:4, pages 601-612.
Crossref
Crossref
A. Davidi, J. Reynolds, V. Y. Njike, Y. Ma, K. Doughty & D. L. Katz. (2011) The effect of the addition of daily fruit and nut bars to diet on weight, and cardiac risk profile, in overweight adults. Journal of Human Nutrition and Dietetics 24:6, pages 543-551.
Crossref
Crossref
Kevin C. Maki, Harold E. Bays, Mary R. Dicklin, Susan L. Johnson & Mayadah Shabbout. (2011) Effects of prescription omega-3-acid ethyl esters, coadministered with atorvastatin, on circulating levels of lipoprotein particles, apolipoprotein CIII, and lipoprotein-associated phospholipase A2 mass in men and women with mixed dyslipidemia. Journal of Clinical Lipidology 5:6, pages 483-492.
Crossref
Crossref
Stephan Winnik, Christine Lohmann, Eva K. Richter, Nicola Schäfer, Wen-Liang Song, Florian Leiber, Pavani Mocharla, Janin Hofmann, Roland Klingenberg, Jan Borén, Burkhard Becher, Garret A. FitzGerald, Thomas F. Lüscher, Christian M. Matter & Jürg H. Beer. (2011) Dietary α-linolenic acid diminishes experimental atherogenesis and restricts T cell-driven inflammation. European Heart Journal 32:20, pages 2573-2584.
Crossref
Crossref
Harold E. Bays, Christie M. Ballantyne, John J. Kastelein, Jonathan L. Isaacsohn, Rene A. Braeckman & Paresh N. Soni. (2011) Eicosapentaenoic Acid Ethyl Ester (AMR101) Therapy in Patients With Very High Triglyceride Levels (from the Multi-center, plAcebo-controlled, Randomized, double-blINd, 12-week study with an open-label Extension [MARINE] Trial). The American Journal of Cardiology 108:5, pages 682-690.
Crossref
Crossref
Ira J. GoldbergRobert H. EckelRuth McPherson. (2011) Triglycerides and Heart Disease. Arteriosclerosis, Thrombosis, and Vascular Biology 31:8, pages 1716-1725.
Crossref
Crossref
Carol M. Mason, Janet Long & Cindy Conroy. (2011) Prescription Omega-3s. Journal of Cardiovascular Nursing 26:4, pages 290-297.
Crossref
Crossref
M. John Chapman, Henry N. Ginsberg, Pierre Amarenco, Felicita Andreotti, Jan Borén, Alberico L. Catapano, Olivier S. Descamps, Edward Fisher, Petri T. Kovanen, Jan Albert Kuivenhoven, Philippe Lesnik, Luis Masana, Børge G. Nordestgaard, Kausik K. Ray, Zeljko Reiner, Marja-Riitta Taskinen, Lale Tokgözoglu, Anne Tybjærg-Hansen & Gerald F. Watts. (2011) Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management. European Heart Journal 32:11, pages 1345-1361.
Crossref
Crossref
Kevin C Maki, Andrea L Lawless, Kathleen M Kelley, Mary R Dicklin, Valerie N Kaden, Arianne L Schild, Tia M Rains & John W Marshall. (2011) Effects of Prescription Omega-3-Acid Ethyl Esters on Fasting Lipid Profile in Subjects With Primary Hypercholesterolemia. Journal of Cardiovascular Pharmacology 57:4, pages 489-494.
Crossref
Crossref
Ganesh V. Halade, Paul J. Williams, Merry L. Lindsey & Gabriel Fernandes. (2011) Fish oil decreases inflammation and reduces cardiac remodeling in rosiglitazone treated aging mice. Pharmacological Research 63:4, pages 300-307.
Crossref
Crossref
Yehuda Handelsman, Jeffrey I. Mechanick, Lawrence Blonde, George Grunberger, Zachary T. Bloomgarden, George A. Bray, Samuel Dagogo-Jack, Jaime A. Davidson, Daniel Einhorn, Om Ganda, Alan J. Garber, Irl B. Hirsch, Edward S. Horton, Faramarz Ismail-Beigi, Paul S. Jellinger, Kenneth L. Jones, Lois Jovanovič, Harold Lebovitz, Philip Levy, Etie S. Moghissi, Eric A. Orzeck, Aaron I. Vinik, Kathleen L. Wyne, Alan J. Garber, Daniel L. Hurley & Farhad Zangeneh. (2011) American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for Developing a Diabetes Mellitus Comprehensive Care Plan. Endocrine Practice 17, pages 1-53.
Crossref
Crossref
Michael J. Puglisi, Alyssa H. Hasty & Viswanathan Saraswathi. (2011) The role of adipose tissue in mediating the beneficial effects of dietary fish oil. The Journal of Nutritional Biochemistry 22:2, pages 101-108.
Crossref
Crossref
Alison M. Hill, Kristina A. Harris, Alison M. Coates & Penny M. Kris-Etherton. 2011. Preventive Cardiology: Companion to Braunwald's Heart Disease. Preventive Cardiology: Companion to Braunwald's Heart Disease
253
271
.
Robert H. Eckel. (2010) The Fish Oil Story Remains Fishy. Circulation 122:21, pages 2110-2112.
Crossref
Crossref
Nassima Bouzidi, Khedidja Mekki, Ali Boukaddoum, Nawel Dida, Abbou Kaddous & Malika Bouchenak. (2010) Effects of Omega-3 Polyunsaturated Fatty-Acid Supplementation on Redox Status in Chronic Renal Failure Patients With Dyslipidemia. Journal of Renal Nutrition 20:5, pages 321-328.
Crossref
Crossref
Marika Massaro, Egeria Scoditti, Maria Annunziata Carluccio & Raffaele De Caterina. (2010) Nutraceuticals and Prevention of Atherosclerosis: Focus on ω‐3 Polyunsaturated Fatty Acids and Mediterranean Diet Polyphenols. Cardiovascular Therapeutics 28:4.
Crossref
Crossref
Brad McEwen, Marie-Christine Morel-Kopp, Geoffrey Tofler & Christopher Ward. (2010) Effect of Omega-3 Fish Oil on Cardiovascular Risk in Diabetes. The Diabetes Educator 36:4, pages 565-584.
Crossref
Crossref
Harold E. Bays, James McKenney, Kevin C. Maki, Ralph T. Doyle, Roderick N. Carter & Evan Stein. (2010) Effects of Prescription Omega-3-Acid Ethyl Esters on Non—High-Density Lipoprotein Cholesterol When Coadministered With Escalating Doses of Atorvastatin. Mayo Clinic Proceedings 85:2, pages 122-128.
Crossref
Crossref
Om P. Ganda. 2010. Principles of Diabetes Mellitus. Principles of Diabetes Mellitus
435
456
.
Viswanathan Saraswathi, Jason D. Morrow & Alyssa H. Hasty. (2009) Dietary Fish Oil Exerts Hypolipidemic Effects in Lean and Insulin Sensitizing Effects in Obese LDLR−/− Mice. The Journal of Nutrition 139:12, pages 2380-2386.
Crossref
Crossref
David M. Owen, Hua Huang, Jin Ye & Michael GaleJr.Jr.. (2009) Apolipoprotein E on hepatitis C virion facilitates infection through interaction with low-density lipoprotein receptor. Virology 394:1, pages 99-108.
Crossref
Crossref
Jadwiga Hartwich, Malgorzata Malczewska Malec, Lukasz Partyka, Pablo Pérez-Martinez, Carmen Marin, Jose López-Miranda, Audrey C. Tierney, Jolene Mc Monagle, Helen M. Roche, Catherine Defoort, Pawel Wolkow & Aldona Dembinska-Kieć. (2009) The effect of the plasma n-3/n-6 polyunsaturated fatty acid ratio on the dietary LDL phenotype transformation – Insights from the LIPGENE study. Clinical Nutrition 28:5, pages 510-515.
Crossref
Crossref
H. E. Bays, B. Laferrère, J. Dixon, L. Aronne, J. M. González-Campoy, C. Apovian & B. M. Wolfe. (2009) Adiposopathy and bariatric surgery: is ‘sick fat’ a surgical disease?. International Journal of Clinical Practice 63:9, pages 1285-1300.
Crossref
Crossref
Eli M Roth, Harold E Bays, Alan D Forker, Kevin C Maki, Roderick Carter, Ralph T Doyle & Evan A Stein. (2009) Prescription Omega-3 Fatty Acid as an Adjunct to Fenofibrate Therapy in Hypertriglyceridemic Subjects. Journal of Cardiovascular Pharmacology 54:3, pages 196-203.
Crossref
Crossref
Md Mizanur Rahman, Arunabh Bhattacharya, Jameela Banu, Jing X. Kang & Gabriel Fernandes. (2009) Endogenous n‐3 fatty acids protect ovariectomy induced bone loss by attenuating osteoclastogenesis. Journal of Cellular and Molecular Medicine 13:8b, pages 1833-1844.
Crossref
Crossref
Md Mizanur Rahman, Arunabh Bhattacharya, Jameela Banu, Jing X. Kang & Gabriel Fernandes. (2009) Endogenous n-3 fatty acids protect ovariectomy induced bone loss by attenuating osteoclastogenesis. Journal of Cellular and Molecular Medicine 13:8b, pages 1833-1844.
Crossref
Crossref
Carl J. Lavie, Richard V. Milani, Mandeep R. Mehra & Hector O. Ventura. (2009) Omega-3 Polyunsaturated Fatty Acids and Cardiovascular Diseases. Journal of the American College of Cardiology 54:7, pages 585-594.
Crossref
Crossref
Sheridan M. Hoy & Gillian M. Keating. (2009) Omega-3 Ethylester Concentrate. Drugs 69:8, pages 1077-1105.
Crossref
Crossref
Tara L. Dall & Harold Bays. (2009) Addressing Lipid Treatment Targets Beyond Cholesterol: A Role for Prescription Omega-3 Fatty Acid Therapy. Southern Medical Journal 102:4, pages 390-396.
Crossref
Crossref
Dolores Corella. (2008) Diet-gene interactions between dietary fat intake and common polymorphisms in determining lipid metabolism. Grasas y Aceites 60:1.
Crossref
Crossref
Donald P Kotler. (2008) HIV and Antiretroviral Therapy: Lipid Abnormalities and Associated Cardiovascular Risk in HIV-Infected Patients. JAIDS Journal of Acquired Immune Deficiency Syndromes 49:Supplement 2, pages S79-S85.
Crossref
Crossref
Megan Brelsford & Trisha Clarke Beute. (2008) Preventing and Managing the Side Effects of Isotretinoin. Seminars in Cutaneous Medicine and Surgery 27:3, pages 197-206.
Crossref
Crossref
Marika Massaro, Egeria Scoditti, Maria Annunziata Carluccio & Raffaele De Caterina. (2008) Basic mechanisms behind the effects of n-3 fatty acids on cardiovascular disease. Prostaglandins, Leukotrienes and Essential Fatty Acids 79:3-5, pages 109-115.
Crossref
Crossref
P. M. Ferraro, G. F. Ferraccioli, G. Gambaro, P. Fulignati & S. Costanzi. (2008) Combined treatment with renin-angiotensin system blockers and polyunsaturated fatty acids in proteinuric IgA nephropathy: a randomized controlled trial. Nephrology Dialysis Transplantation 24:1, pages 156-160.
Crossref
Crossref
Brian M. Ross. (2008) Article Commentary: The Emerging Role of Eicosapentaenoic Acid as an Important Psychoactive Natural Product: Some Answers but a Lot more Questions. Lipid Insights 2, pages LPI.S1013.
Crossref
Crossref